BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 7561077)

  • 1. B lymphocytes can be competent antigen-presenting cells for priming CD4+ T cells to protein antigens in vivo.
    Constant S; Schweitzer N; West J; Ranney P; Bottomly K
    J Immunol; 1995 Oct; 155(8):3734-41. PubMed ID: 7561077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B lymphocytes as antigen-presenting cells for CD4+ T cell priming in vivo.
    Constant SL
    J Immunol; 1999 May; 162(10):5695-703. PubMed ID: 10229801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splenic dendritic cells pulsed with Ixodes ricinus tick saliva prime naive CD4+T to induce Th2 cell differentiation in vitro and in vivo.
    Mejri N; Brossard M
    Int Immunol; 2007 Apr; 19(4):535-43. PubMed ID: 17344202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of dendritic cells in the priming of CD4+ T lymphocytes to peptide antigen in vivo.
    Levin D; Constant S; Pasqualini T; Flavell R; Bottomly K
    J Immunol; 1993 Dec; 151(12):6742-50. PubMed ID: 7903097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time dependence of B cell processing and presentation of peptide and native protein antigens.
    Lakey EK; Casten LA; Niebling WL; Margoliash E; Pierce SK
    J Immunol; 1988 May; 140(10):3309-14. PubMed ID: 2834435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of IL-4-producing CD4+ T cells by antigenic peptides altered for TCR binding.
    Tao X; Grant C; Constant S; Bottomly K
    J Immunol; 1997 May; 158(9):4237-44. PubMed ID: 9126985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of lung dendritic cells and B cells in stimulating naive antigen-specific T cells.
    Masten BJ; Lipscomb MF
    J Immunol; 1999 Feb; 162(3):1310-7. PubMed ID: 9973384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+ T cell responses to CD40-deficient APCs: defects in proliferation and negative selection apply only with B cells as APCs.
    Ozaki ME; Coren BA; Huynh TN; Redondo DJ; Kikutani H; Webb SR
    J Immunol; 1999 Nov; 163(10):5250-6. PubMed ID: 10553046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD40 ligand induction on T cell subsets by peptide-presenting B cells: implications for development of the primary T and B cell response.
    Jaiswal AI; Croft M
    J Immunol; 1997 Sep; 159(5):2282-91. PubMed ID: 9278317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concerted antigen presentation by dendritic cells and B cells is necessary for optimal CD4 T-cell immunity in vivo.
    Kleindienst P; Brocker T
    Immunology; 2005 Aug; 115(4):556-64. PubMed ID: 16011524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD40 is necessary for activation of naïve T cells by a dendritic cell line in vivo but not in vitro.
    Haase C; Michelsen BK; Jørgensen TN
    Scand J Immunol; 2004 Mar; 59(3):237-45. PubMed ID: 15030573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses.
    Gramaglia I; Weinberg AD; Lemon M; Croft M
    J Immunol; 1998 Dec; 161(12):6510-7. PubMed ID: 9862675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated B cells express CD28/B7-independent costimulatory activity.
    Ding L; Shevach EM
    J Immunol; 1996 Aug; 157(4):1389-96. PubMed ID: 8759718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B7 costimulation and autoantigen specificity enable B cells to activate autoreactive T cells.
    Roth R; Nakamura T; Mamula MJ
    J Immunol; 1996 Oct; 157(7):2924-31. PubMed ID: 8816398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential up-regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen.
    Lenschow DJ; Sperling AI; Cooke MP; Freeman G; Rhee L; Decker DC; Gray G; Nadler LM; Goodnow CC; Bluestone JA
    J Immunol; 1994 Sep; 153(5):1990-7. PubMed ID: 7519638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-specific B cells preferentially induce CD4+ T cells to produce IL-4.
    Macaulay AE; DeKruyff RH; Goodnow CC; Umetsu DT
    J Immunol; 1997 May; 158(9):4171-9. PubMed ID: 9126977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen-primed T cells from B cell-deficient JHD mice fail to provide B cell help.
    Macaulay AE; DeKruyff RH; Umetsu DT
    J Immunol; 1998 Feb; 160(4):1694-700. PubMed ID: 9469426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo priming of helper T cells in the absence of B cell activation.
    Fox BS; Dordai D; Moore RL; Lacy BE
    J Immunol; 1989 Dec; 143(12):3887-93. PubMed ID: 2556472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term administration of ethanol in mice deviates antigen presentation activity towards B cells.
    Andrade MC; Albernaz MJ; Araújo MS; Santos BP; Teixeira-Carvalho A; Faria AM; Martins-Filho OA
    Scand J Immunol; 2009 Sep; 70(3):226-37. PubMed ID: 19703012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The infection of human dendritic cells with recombinant avipox vectors expressing a costimulatory molecule transgene (CD80) to enhance the activation of antigen-specific cytolytic T cells.
    Tsang KY; Zhu M; Even J; Gulley J; Arlen P; Schlom J
    Cancer Res; 2001 Oct; 61(20):7568-76. PubMed ID: 11606396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.